ESSA Pharma Inc. (EPIX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ESSA Pharma Inc.

    NASDAQ: EPIX · Real-Time Price · USD
    0.26
    -0.52 (-66.83%)
    At close: Aug 26, 2025, 3:59 PM

    ESSA Pharma Income Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 90.68K 118.49K 121.79K 109.46K
    Gross Profit
    		 -90.68K -118.49K -121.79K -109.46K
    Operating Income
    		 -34.42M -32.13M -35.34M -36.91M
    Interest Income
    		 5.87M 5.55M 1.74M 235K
    Pretax Income
    		 -28.54M -26.58M -35.22M -36.84M
    Net Income
    		 -28.54M -26.58M -35.1M -36.81M
    Selling & General & Admin
    		 13.21M 10.81M 12.54M 12.78M
    Research & Development
    		 21.21M 21.32M 24.41M 24.26M
    Other Expenses
    		 n/a n/a n/a 109.46K
    Operating Expenses
    		 34.42M 32.13M 36.96M 37.14M
    Interest Expense
    		 n/a 6.94K 14K 22.22K
    Selling & Marketing Expenses
    		 134.09K 22.57K n/a n/a
    Cost & Expenses
    		 34.42M 32.13M 36.96M 37.14M
    Income Tax Expense
    		 n/a 1.6K -112K -34.35K
    Shares Outstanding (Basic)
    		 44.28M 44.09M 44.04M 38.48M
    Shares Outstanding (Diluted)
    		 44.28M 44.09M 44.04M 38.48M
    EPS (Basic)
    		 -0.64 -0.6 -0.8 -0.96
    EPS (Diluted)
    		 -0.64 -0.6 -0.8 -0.96
    EBITDA
    		 -28.45M -26.46M -35.08M -36.71M
    EBIT
    		 -28.54M -26.57M -35.2M -36.82M
    Depreciation & Amortization
    		 90.68K 118.49K 121.79K 109.46K

    Add to Watchlist